Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Trial details
- Registry ID
- NCT05696626
- Drugs studied
- Fulvestrant in combination with abemaciclib, Lasofoxifene in combination with abemaciclib